
Test once. Know.
Delve Bio is a clinical diagnostics company on a mission to revolutionize infectious disease testing by bringing metagenomic next-generation sequencing (mNGS) testing out of the research lab and into the clinic. Founded by leading experts in infectious disease, Delve Bio's platform enables clinicians to test once and know — ending the era of sequential, time-consuming guess-and-test diagnostics. The company's Delve Detect product connects clinicians with medical experts for clinical consults and result interpretation, leveraging mNGS to identify pathogens across a broad range of infectious diseases in a single test.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJun 2023
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...

Global clinical research organization specializing in early-stage clinical trials and bioanalytic...

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...